A 12 Week Treatment, Multi-center, Randomized, Double-blind, Parallel-group, Placebo and Active Controlled Study to Assess the Efficacy, Safety, and Tolerability of Indacaterol Maleate / Glycopyrronium Bromide in COPD Patients With Moderate to Severe Airflow Limitation.
Clinical trial NCT01727141 · COMPLETED
Trial details
- NCT number
- NCT01727141
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-11-01
- Primary completion
- 2014-02-01
- Enrollment
- 1042
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.